top of page

Mark Lebwohl, MD


  • Dean for Clinical Therapeutics and Chairman emeritus of DermatologyIcahn School of Medicine at Mount Sinai

Mark Lebwohl, MD, is the Kimberly and Eric J. Waldman Professor and Chairman, Kimberly and Eric J. Waldman Department of Dermatology at the Icahn School of Medicine at Mount Sinai in New York, New York, USA He received his degree in medicine from Harvard Medical School in Boston, Massachusetts, USA, and completed his internship and residency in internal medicine, as well as his residency in dermatology at Mount Sinai Hospital in New York. His key interests in clinical research include skin cancer and inflammatory skin diseases including psoriasis, atopic dermatitis. Vitiligo and alopecia areata. Dr. Lebwohl identified one of the first topical therapies approved for skin cancer and precancerous lesions. In addition, many of the systemic and topical therapies for psoriasis and atopic dermatitis were investigated or developed in the Department of Dermatology at Mount Sinai. Dr. Lebwohl has authored or co-authored nearly 500 original peer-reviewed original reports, 400 invited articles and other publications, and approximately 250 abstracts. Notably, he is the author of the first atlas, Atlas of the Skin of Systemic Disease, which is dedicated to cutaneous manifestations of systemic disease and co-editor of Treatment of Skin Disease, a leading textbook in dermatology that has been translated into several languages, won several medical book awards, and is in its 5th edition. Dr. Lebwohl is the founding editor of the Journal of Psoriasis and Psoriatic Arthritis and of Skin, the Journal of Cutaneous Medicine. He has served on the editorial boards of the Journal of the European Academy of Dermato-Venereology, the Latin American Journal of Psoriasis and Psoriatic Arthritis, the Journal of Skin Cancer, and the Journal of the American Academy of Dermatology. Currently, he is editor of the dermatology section of Scientific American Medicine. In addition, as a renowned expert in dermatology, Dr. Lebwohl is frequently an invited visiting professor and speaker at universities, medical centers, conferences, and symposia worldwide. Active in a number of professional organizations, Dr. Lebwohl is an honorary member of the French Society of Dermatology and the Canadian Dermatology Association. He is past president of the American Academy of Dermatology and Chairman Emeritus of the Medical Board of the National Psoriasis Foundation. Dr. Lebwohl serves on the International Psoriasis Council. Throughout his distinguished career, Dr. Lebwohl has been the recipient of many awards, such as the Presidential Citation from the American Academy of Dermatology for his service to the AAD on psoriasis and for his work with the Psoriasis Foundation. Furthermore, he has received Lifetime Achievement Awards from the National Psoriasis Foundation and American Skin Association and has been recognized as a Leader of Distinction by the Journal of Drugs in Dermatology for his work in psoriasis. In addition, Dr. Lebwohl was the honorary chairman of the 1st World Psoriasis and Psoriatic Arthritis Conference held in Stockholm, Sweden in 2006 by the International Federation of Psoriasis Associations and its patron, His Majesty King Carl Gustav of Sweden.

bottom of page